Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CLEO Diagnostics Ltd ( (AU:COV) ) just unveiled an announcement.
Cleo Diagnostics Limited reported a 12.8% decrease in revenues to $339,590 for the year ending June 30, 2025, alongside a 6.4% increase in losses, totaling $3,999,134. The company did not declare any dividends for the period, and the net tangible assets per ordinary security decreased from 6.99 cents to 4.26 cents, indicating financial challenges and potential implications for stakeholders.
More about CLEO Diagnostics Ltd
Cleo Diagnostics Limited operates in the healthcare industry, focusing on diagnostic services and products. The company is involved in developing and providing diagnostic solutions, although specific market focus details are not provided.
Average Trading Volume: 68,152
Technical Sentiment Signal: Hold
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.